AMAG Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AMAG and buy or sell other stocks, ETFs, and their options commission-free!About AMAG
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme.
CEOMichael Porter, MBA
CEOMichael Porter, MBA
Employees—
Employees—
HeadquartersBerkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded1981
Founded1981
Employees—
Employees—
AMAG Key Statistics
Market cap477.47M
Market cap477.47M
Price-Earnings ratio-2.04
Price-Earnings ratio-2.04
Dividend yield—
Dividend yield—
Average volume1.24M
Average volume1.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.80
52 Week high$13.80
52 Week low$4.41
52 Week low$4.41
Stock Snapshot
As of today, AMAG Pharmaceuticals(AMAG) shares are valued at $13.75. The company's market cap stands at 477.47M, with a P/E ratio of -2.04.
AMAG Pharmaceuticals(AMAG) stock opened on 2025-11-08 at —. The price climbed to — and dipped to —.
The AMAG Pharmaceuticals(AMAG)'s current trading volume is 0, compared to an average daily volume of 1.24M.
During the past year, AMAG Pharmaceuticals(AMAG) stock moved between $4.41 at its lowest and $13.80 at its peak.
During the past year, AMAG Pharmaceuticals(AMAG) stock moved between $4.41 at its lowest and $13.80 at its peak.
People also own
Based on the portfolios of people who own AMAG. This list is generated using Robinhood data, and it’s not a recommendation.